Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting No phase listed Observational

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

ClinicalTrials.gov ID: NCT04981119

Public ClinicalTrials.gov record NCT04981119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 6, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing

Study identification

NCT ID
NCT04981119
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
A2 Biotherapeutics Inc.
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • Apheresis Other
  • Long Range NGS HLA typing Diagnostic Test
  • Next Generation Sequencing (NGS) Diagnostic Test

Other · Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2021
Primary completion
Nov 30, 2028
Completion
Mar 31, 2029
Last update posted
Apr 29, 2026

2021 – 2029

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Banner Health Gilbert Arizona 85234 Recruiting
Mayo Clinic Hospital Phoenix Arizona 85054 Recruiting
City of Hope Duarte California 90101 Completed
University of California San Diego La Jolla California 92093 Recruiting
Stanford University Palo Alto California 94304 Recruiting
UCLA Medical Center Santa Monica California 90404 Recruiting
Mayo Clinic Jacksonville Jacksonville Florida 32224 Recruiting
Moffitt Cancer Center Tampa Florida 33136 Recruiting
Massachusetts General Hospital/Dana Farber Cancer Institute Boston Massachusetts 02114 Completed
Mayo Clinic Rochester Rochester Minnesota 55905 Recruiting
Washington University St Louis Missouri 63110 Recruiting
NYU Langone Medical Center New York New York 10016 Recruiting
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Completed
Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04981119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04981119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →